Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program
Suzanne M Garland, Alyssa M Cornall, Julia ML Brotherton, John D Wark, Michael J Malloy, Sepehr N Tabrizi
Vaccine | ELSEVIER SCI LTD | Published : 2018
We gratefully acknowledge the Victorian Cancer Agency as our funding body. We thank Elisa Young, Sarah Osborne, Margaret Nugyen, Iris Tung, Fiona Tan and David Hawkes for project management and co-ordination at various periods of the study and Adele Rivers for participant recruitment and management. We also acknowledge Houda Abdo, Angela Hurley, Marin Poljak and Sam Phillips for completing all HPV genotyping analyses and Athena Costa for assisting with the manuscript submission. We thank the NHVPR staff who assisted with the study. The NHVPR is owned by the Australian Government Department of Health and operated by VCS Limited. We especially thank all of the participants who volunteered for the Vaccine study.